Transcript Molmed Symposium - European Society of Gene and Cell Therapy

ESGCT / ISSCR / ABCD COLLABORATIVE CONGRESS 2016
PROGRAMME
TUESDAY 18 OCTOBER 2016
MOLMED SYMPOSIUM
An entrepreneurial approach to translate academic knowledge into
therapeutic solutions for all patients
Ground floor, Botticelli room
13.00-14.00
Registration
14.00-14.15
hen pioneers in cell and gene therapy come up with a ‘business’ idea
W
Claudio Bordignon, Molmed, Milan
14.15-14.30
cademia ready to be a productive partner for biotech companies
A
Fabio Ciceri, San Raffaele Scientific Institute, Milan
14.30-14.45
ow the financial market operated and operates in sustaining the biotech
H
sector development
Gil Bar-Nahum, Jefferies Global Healthcare Group, Bresso
14.45-15.00
picture of the European biotech sector: strengths and weaknesses
A
Carlo Incerti, EuropaBio, Bresso
15.00-15.30
ound Table
R
Moderator: Frediano Finucci (La7)
Martin Andrews, GSK, Brentford
Gil Bar-Nahum, Global Healthcare Group at Jefferies International Limited
Claudio Bordignon, MolMed, Milan
Fabio Ciceri, San Raffaele Scientific Institute, Milan
Carlo Incerti, EuropaBio, Bresso
Francesca Pasinelli, Telethon Foundation
73